Oncology
🇺🇸 FDA Page 12FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 133–144 of 246 articles
Pembrolizumab Expanded Label: KEYNOTE-826 Trial Transforms Advanced Cervical Cancer Care
FDA Approval VX-009: Market Analysis of Oncodex's Oncolytic Virus Therapy
ImmunityBio (IBRX) Faces FDA Warning Letter and Class Action Lawsuit Over Anktiva Claims
Alpha Tau Receives FDA Approval to Expand Alpha DaRT Pancreatic Cancer Trial with Gemcitabine-Abraxane Combination
FDA Guidance on Accelerated Approval: Key Updates for Oncology Drugs
Next-Generation Immunotherapy: Beyond PD-1/PD-L1 Inhibition in US Oncology
Next-Generation Sequencing MEA: Impact on Precision Oncology Treatment Selection
OSE Immunotherapeutics' Tedopi Ovarian Cancer Trial Results Selected for ASCO 2026 Presentation
Greenwich LifeSciences GLSI-100 Abstract Accepted at ASCO 2026 for Breast Cancer Immunotherapy Trial
Mabwell's 9MW2821 Becomes First Nectin-4 ADC to Enter Phase III Trial for Triple-Negative Breast Cancer
Oncology Data Landscape 2026: Key Trends & Upcoming Readouts
Fierce Biotech Week 2026: What to Expect in Boston